Cargando…

Design of acid-responsive polymeric nanoparticles for 7,3′,4′-trihydroxyisoflavone topical administration

7,3′,4′-Trihydroxyisoflavone (734THIF) is a secondary metabolite of daidzein and has been recently found to possess antioxidant, melanin inhibition, and skin cancer chemopreventive activities. However, the poor water solubility of 734THIF impedes its absorption and skin penetration and, therefore, l...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Pao-Hsien, Hu, Stephen Chu-Sung, Lee, Chiang-Wen, Yeh, An-Chi, Tseng, Chih-Hua, Yen, Feng-Lin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4841439/
https://www.ncbi.nlm.nih.gov/pubmed/27143883
http://dx.doi.org/10.2147/IJN.S100418
_version_ 1782428394965696512
author Huang, Pao-Hsien
Hu, Stephen Chu-Sung
Lee, Chiang-Wen
Yeh, An-Chi
Tseng, Chih-Hua
Yen, Feng-Lin
author_facet Huang, Pao-Hsien
Hu, Stephen Chu-Sung
Lee, Chiang-Wen
Yeh, An-Chi
Tseng, Chih-Hua
Yen, Feng-Lin
author_sort Huang, Pao-Hsien
collection PubMed
description 7,3′,4′-Trihydroxyisoflavone (734THIF) is a secondary metabolite of daidzein and has been recently found to possess antioxidant, melanin inhibition, and skin cancer chemopreventive activities. However, the poor water solubility of 734THIF impedes its absorption and skin penetration and, therefore, limits its pharmacological effects when applied topically to the skin. We seek to use the nanoprecipitation method to prepare optimal eudragit E100 (EE)–polyvinyl alcohol (PVA)-loaded 734THIF nanoparticles (734N) to improve its physicochemical properties and thereby increase its water solubility, skin penetration, and biological activities. EE–PVA-loaded 734THIF nanoparticles (734N) were prepared, and their morphology and particle size were evaluated using a particle size analyzer and by electron microscopy. The drug loading and encapsulation efficiencies and in vitro solubility were determined using high-performance liquid chromatography. Hydrogen-bond formation was evaluated by (1)H-nuclear magnetic resonance and Fourier transform infrared spectroscopy, and crystalline-to-amorphous transformation was determined by differential scanning calorimetry and X-ray diffractometry. In vitro skin penetration was analyzed using fresh pig skin mounted on Franz diffusion cells, and cytotoxicity against human keratinocyte HaCaT cells was evaluated using the MTT assay. Antioxidant activity was determined by 2,2-diphenyl-1-picrylhydrazyl-free radical scavenging ability. EE–PVA-loaded 734THIF nanoparticles showed good drug loading and encapsulation efficiencies and were characterized by improved physicochemical properties, including reduction in particle size, amorphous transformation, and intermolecular hydrogen-bond formation. This is associated with increased water solubility and enhanced in vitro skin penetration, with no cytotoxicity toward HaCaT cells. In addition, 734THIF nanoparticles retained their antioxidant activity. In conclusion, 734THIF nanoparticles are characterized by improved physicochemical properties, increased water solubility, and enhanced skin penetration, and these may have potential use in the future as a topical delivery formulation for the treatment of skin diseases.
format Online
Article
Text
id pubmed-4841439
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-48414392016-05-03 Design of acid-responsive polymeric nanoparticles for 7,3′,4′-trihydroxyisoflavone topical administration Huang, Pao-Hsien Hu, Stephen Chu-Sung Lee, Chiang-Wen Yeh, An-Chi Tseng, Chih-Hua Yen, Feng-Lin Int J Nanomedicine Original Research 7,3′,4′-Trihydroxyisoflavone (734THIF) is a secondary metabolite of daidzein and has been recently found to possess antioxidant, melanin inhibition, and skin cancer chemopreventive activities. However, the poor water solubility of 734THIF impedes its absorption and skin penetration and, therefore, limits its pharmacological effects when applied topically to the skin. We seek to use the nanoprecipitation method to prepare optimal eudragit E100 (EE)–polyvinyl alcohol (PVA)-loaded 734THIF nanoparticles (734N) to improve its physicochemical properties and thereby increase its water solubility, skin penetration, and biological activities. EE–PVA-loaded 734THIF nanoparticles (734N) were prepared, and their morphology and particle size were evaluated using a particle size analyzer and by electron microscopy. The drug loading and encapsulation efficiencies and in vitro solubility were determined using high-performance liquid chromatography. Hydrogen-bond formation was evaluated by (1)H-nuclear magnetic resonance and Fourier transform infrared spectroscopy, and crystalline-to-amorphous transformation was determined by differential scanning calorimetry and X-ray diffractometry. In vitro skin penetration was analyzed using fresh pig skin mounted on Franz diffusion cells, and cytotoxicity against human keratinocyte HaCaT cells was evaluated using the MTT assay. Antioxidant activity was determined by 2,2-diphenyl-1-picrylhydrazyl-free radical scavenging ability. EE–PVA-loaded 734THIF nanoparticles showed good drug loading and encapsulation efficiencies and were characterized by improved physicochemical properties, including reduction in particle size, amorphous transformation, and intermolecular hydrogen-bond formation. This is associated with increased water solubility and enhanced in vitro skin penetration, with no cytotoxicity toward HaCaT cells. In addition, 734THIF nanoparticles retained their antioxidant activity. In conclusion, 734THIF nanoparticles are characterized by improved physicochemical properties, increased water solubility, and enhanced skin penetration, and these may have potential use in the future as a topical delivery formulation for the treatment of skin diseases. Dove Medical Press 2016-04-18 /pmc/articles/PMC4841439/ /pubmed/27143883 http://dx.doi.org/10.2147/IJN.S100418 Text en © 2016 Huang et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Huang, Pao-Hsien
Hu, Stephen Chu-Sung
Lee, Chiang-Wen
Yeh, An-Chi
Tseng, Chih-Hua
Yen, Feng-Lin
Design of acid-responsive polymeric nanoparticles for 7,3′,4′-trihydroxyisoflavone topical administration
title Design of acid-responsive polymeric nanoparticles for 7,3′,4′-trihydroxyisoflavone topical administration
title_full Design of acid-responsive polymeric nanoparticles for 7,3′,4′-trihydroxyisoflavone topical administration
title_fullStr Design of acid-responsive polymeric nanoparticles for 7,3′,4′-trihydroxyisoflavone topical administration
title_full_unstemmed Design of acid-responsive polymeric nanoparticles for 7,3′,4′-trihydroxyisoflavone topical administration
title_short Design of acid-responsive polymeric nanoparticles for 7,3′,4′-trihydroxyisoflavone topical administration
title_sort design of acid-responsive polymeric nanoparticles for 7,3′,4′-trihydroxyisoflavone topical administration
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4841439/
https://www.ncbi.nlm.nih.gov/pubmed/27143883
http://dx.doi.org/10.2147/IJN.S100418
work_keys_str_mv AT huangpaohsien designofacidresponsivepolymericnanoparticlesfor734trihydroxyisoflavonetopicaladministration
AT hustephenchusung designofacidresponsivepolymericnanoparticlesfor734trihydroxyisoflavonetopicaladministration
AT leechiangwen designofacidresponsivepolymericnanoparticlesfor734trihydroxyisoflavonetopicaladministration
AT yehanchi designofacidresponsivepolymericnanoparticlesfor734trihydroxyisoflavonetopicaladministration
AT tsengchihhua designofacidresponsivepolymericnanoparticlesfor734trihydroxyisoflavonetopicaladministration
AT yenfenglin designofacidresponsivepolymericnanoparticlesfor734trihydroxyisoflavonetopicaladministration